Explore more publications!

France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

Press releases published on February 9, 2026

HIP Video Promo Presents: HighWay releases all new ‘¡BANG BANG!’ music video
Mersen USA Union Workers Picket Plant to Protest Third Announcement of Job Cuts
Influence Society dévoile SOCIETIES 2025 : une publication visionnaire qui redéfinit les codes du branding hôtelier
City of Hollywood Becomes One of the First in Florida to Launch Overdose Emergency Cabinet Program
European response to cyber physical threats in the food industry. The ACT4FOOD project officially launched
Turki Alalshikh: Riyadh Season Tops Brands in Middle East and North Africa & Secures First Place at Loeries Awards
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities
European University Association Annual Conference to Be Held in Istanbul
Terra Firma Energy Reports Strong First Year of Full Operations at their 5MW Droitwich flexible generation site.
Plag Élimine les Barrières de Coût pour l'Intégrité Académique
Dr. Juan Phillip Chisholm Wins a Cine Paris Film Festival Award for 'Mission Possible Book Award' Film in Paris, France
Ministry of Transport to Host 2nd Autonomous e-Mobility Forum in April
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
AB Science annonce que la Food and Drug Administration (FDA) américaine a accordé le statut de Minor Use in Major Species (MUMS) au Masivet® dans le traitement des tumeurs mastocytaires chez le chien
Invitation: Vallourec Q4 2025 Results Release and Conference Call - Friday, February 27th, 2026
TSplus Promotes Thomas Montalcino to Chief Technology Officer
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
Communiqué de presse: Le rilzabrutinib de Sanofi a été désigné comme thérapie innovante aux États-Unis et comme médicament orphelin au Japon pour le traitement de l’anémie hémolytique auto-immune à anticorps chauds
STMicroelectronics expands strategic engagement with Amazon Web Services to enable new high performance compute infrastructure for cloud and AI data centers

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions